NVG-291

· NervGen Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NVG-291, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: NVG-291 in Spinal Cord Injury Subjects [Phase 1, Phase 2]